(1-METHYL-3-OXO-CYCLOBUTYL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

METHYL 3-BROMO-5-FLUORO-4-METHYLBENZOATE, 95.0%, 25g

N-methyl-1-(5-phenyl-1,3,4-oxadiazol-2-yl)methanamine hydrochloride, 95.0%, 5g

3-Fluoropiperidine hydrochloride, 97.0%, 250mg

2-bromo-1-(naphthalen-2-yl)ethan-1-one, 95.0%, 100g

4-Chloro-3-methoxyphenylboronic acid pinacol ester, 97.0%, 250mg

5-Amino-4,4-dimethyl-3,4-dihydroisoquinolin-1(2H)-one, >95%, 1g

Hexythiazox>98.0%(HPLC)(N)250mg

2-Fluoro-4-methoxy-5-nitrobenzaldehyde, 98%, 250mg

(4R,4'R)-2,2'-(PROPANE-2,2-DIYL)BIS(4-METHYL-4,5-DIHYDROOXAZOLE), 95%, 1g

2-(2,5-Dimethyl-1H-pyrrol-1-yl)phenylamine, 5g

Closing caps, Gesch. front, Ø 20 mm 500 pcs

BIBR 1087 SE, 10mg